Efter indgivelse af NovoSeven har protrombintid (PT) og aktiveret partiel tromboplastintid (APTT) vist sig at blive forkortede, men der er ikke påvist nogen korrelation mellem PT og APTT og den kliniske effekt af NovoSeven.
After administration of NovoSeven, prothrombin time (PT) and activated partial thromboplastin time (aPTT) have been shown to shorten, however no correlation has been demonstrated between PT and aPTT and clinical efficacy of NovoSeven.